|
|
 |
|
Viewing report
|
|
|
|
CNS European Market Competitive Strategies - Competitive Analysis, Profiles and Portfolio Strategies of the Top 20 CNS Therapeutic Manufacturers in Europe (2001 Edition)
ADIS, Jan 2002, Pages: 251
The European central nervous system (CNS) disorder marketplace is extremely competitive, a situation which is likely to increase in intensity in the period to 2005.
To succeed in this therapeutic area in the long term, participants need a range of different core competencies.
A high level of ability is critical across the whole range of required competencies in order to achieve success.
The 20 companies profiled in this report essentially fall into one of three categories.
Customers who bought this item also bought
The CNS Market Outlook to 2010
CNS - Competitive Analysis, Profiles and Portfolio Strategies of CNS Therapeutic Manufacturers in the US, 2002
Autoimmune/Inflammatory Disease: Competitive Strategies - Competitive Analysis, Profiles, and Portfolio Strategies of the Top Autoimmune/Inflammatory Therapeutic Manufacturers in the US (2001 Edition)
Portfolio Management in CNS: Composite Portfolio Analysis of Eli Lilly and Novartis
The CNS Outlook to 2007
Top CNS Portfolios in 2004 - The Industry Gold Standards
Respiratory Competitive Strategies: Competitive Analysis, Profiles and Portfolio Strategies of the Top 10 Respiratory Therapeutic Manufacturers in the US (2001 Edition)
Strategic Perspectives: CNS Portfolio Analysis - The Commercial Opportunities and Pitfalls of Company Growth Strategies
|
|
|
|
